OpenAlex
PricingAboutJobs
Log inGet started
Work

ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth

HTML

Year: 2018
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-17-0848
Authors: George A. Ward, Edward J. Lewis, Jong Sook Ahn, Christopher N. Johnson, John F. Lyons, Vanessa Martins, Joanne M. Munck, Sharna J. Rich, Tomoko Smyth, Neil T. Thompson, Pamela A. Williams, Nicola E. Wilsher, Nicola G. Wallis, Gianni Chessari
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: inhibitor of apoptosis proteins, BIR3 domain, Smac/DIABLO, non-canonical NF-κB signaling, caspase-9, proteasomal degradation, breast cancer xenografts, melanoma xenografts, tumor growth inhibition, fragment-based drug discovery
SDG: Good health and well-being

Open Access status: closed

Funder: Astex Pharmaceuticals
OpenAlex ID: W2802542587
FWCI: 2.712
Cites: 49
Cited by: 88
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security